pS2, a 60-amino-acid chain peptide which is the most widespread estrogen-induced RNA messenger in MCF-7 breast cancer cells, is normally detected in the epithelium of gastric mucosa. The aims of this work were to evaluate the cytosolic pS2 content and its clinical significance in gastric carcinomas. Cytosolic pS2 levels were examined by immunoradiometric methods in 108 patients with primary gastric adenocarcinomas. The mean follow-up period was 23.3 months. The cytosolic pS2 levels of the tumors ranged widely, i.e., from 0.1 to 3217 ng/mg protein. There were no significant differences in pS2 content between tumors (mean ± standard error: 137.2±31.4 ng/mg protein) and paired adjacent mucosa samples (n=84; mean ± standard error: 249.6±32.6 ng/mg protein), nor were there any significant differences in tumoral pS2 levels with respect to clinicopathologic parameters such as patient age and sex or tumor location, stage, histologic type or grade. However, the results indicated that high intratumoral pS2 levels were significantly and independently associated with an unfavorable outcome in the overall group of patients (p=0.0266) and in patients with resectable gastric cancer (p=0.003). In conclusion, pS2 may represent a useful biological marker in gastric cancer.
ThimL.A new family of growth factor-like peptides: ‘trefoil’ disulphide loop structures as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP) and frog skin peptides (spasmolysins).FEBS Lett1989; 250: 85–90.
PallaudC., Le DoussalV., PichonM.F., Prud'hommeJ.F., HaceneK., MilgromE.Immunohistochemistry of pS2 in normal human breast and in various histological forms of breast tumours.Histopathology1993; 23: 249–56.
4.
HähnelE., RobbinsP., HáhnelR.Expression of the pS2 gene in normal breast tissue.Breast Cancer Res Treat1993; 28: 295–7.
5.
RioM.C., BellocqJ.P., DanielJ.Y.Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa.Science1988; 241: 705–8.
6.
LuqmaniY., BennettC., PatersonI.Expression of the pS2 gene in normal, benign and neoplastic human stomach.Int J Cancer1989; 44: 806–12.
7.
HenryJ.A., BennettM.K., PiggottN.H., LevettD.L., MayF.E., WestleyB.R.Expression of the pNR-2/pS2 protein in diverse human epithelial tumours.Br J Cancer1991; 64: 677–82.
8.
TheisingerB., WelterC., SeitzG.Expression of the breast cancer associated gene pS2 and the pancreatic spasmolytic polypeptide gene (hSP) in diffuse type stomach carcinoma.Eur J Cancer1991; 27: 770–3.
9.
MüllerW., BorchardF.pS2 protein in gastric carcinoma and normal gastric mucosa: association with clinicopathological parameters and patient survival.J Pathol1993; 171: 263–9.
10.
HanbyA.M., PoulsomR., SinghS., EliaG., JefferyR.E., WrightN.A.Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach.Gastroenterology1993; 105: 1110–6.
11.
JacowlewS.B., BreathnachR., JeltschJ.M., MasiakowskiP., ChambonP.Sequence of the pS2 mRNA induced by estrogen in human breast cancer cell line MCF-7.Nucleic Acids Res1984; 12: 2861–78.
12.
SoubeyranI., QuenelN., CoindreJ.M.pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients.Br J Cancer1996; 74: 1120–5.
13.
HigashiyamaM., DoiO., KodamaK.Prognostic significance of pS2 protein expression in pulmonary adenocarcinoma.Eur J Cancer1994; 30: 792–7.
14.
HigashiyamaM., DoiO., KodamaK., YokouchiH., InajiH., TateishiR.Estimation of serum pS2 protein in patients with lung adenocarcinoma.Anticancer Res1996; 16: 2351–6.
15.
WelterC., TheisingerB., SeitzG.Association of the human spasmolytic polypeptide acid and an oestrogen-induced breast cancer protein (pS2) with human pancreatic carcinoma.Lab Invest1992; 66: 187–92.
16.
CollierJ.D., BennettM.K., BassendineM.F., LendrumR.Immunolocalisation of pS2, a putative growth factor, in pancreatic carcinoma.J Gastroenterol Hepatol1995; 10: 296–300.
17.
TaupinD., OoiK., YeomansN., GiraudA.Conserved expression of intestinal trefoil factor in the human colonic adenoma-adenocarcinoma sequence.Lab Invest1996; 75: 25–32.
18.
HäckelC., FalkenbergB., GüntherT., LippertH., RoessnerA.The pS2 protein in colorectal carcinomas and metastases.Pathol Res Pract1998; 194: 171–6.
19.
JuncoA., RodríguezJ.C., RaigosoP.F., García-MuñizJ.L., GonzálezJ.J., VizosoF.The pS2 protein in primary colorectal carcinomas and in surrounding mucosa.Int J Biol Markers1999; 14: 189–91.
20.
BonkhoffH., SteinU., WelterC., RembergerK.Differential expression of the pS2 protein in the human prostate and prostate cancer: association with premalignant changes and neuroendocrine differentiation.Hum Pathol1995; 26: 824–8.
21.
LipponenP.K., EskelinenM.J.Expression of pS2 protein in transitional cell bladder tumors.J Pathol1994; 173: 327–32.
22.
WangD.G., LiuW.H., LundyF.T.TFF1 gene expression in human medullary thyroid carcinoma.J Pathol1998; 184: 408–13.
23.
HanbyA.M., McKeeP., JefferyM.Primary mucinous carcinomas of the skin express TFF1, TFE3, estrogen receptor, and progesterone receptors.Am J Surg Pathol1998; 22: 1125–31.
24.
WysockiS.J., HahnelE., MastersA., SmithV., McCartneyA.J., HahnelR.Detection of pS2 messenger RNA in gynecological cancers.Cancer Res1990; 50: 1800–2.
25.
SinghS., PoulsomR., WrightN.A., SheppardM.C., LangmanM.J.Differential expression of estrogen receptor and estrogen inducible genes in gastric mucosa and cancer.Gut1997; 40: 516–20.
26.
FujimotoJ., YasuiW., TaharaH.DNA hypermethylation at the pS2 promoter region is associated with early stage of stomach carcinogenesis.Cancer Lett2000; 149: 125–34.
27.
MachadoJ.C., CarneiroF., RibeiroP., BlinN., Sobrinho-SimoesM.pS2 protein expression in gastric carcinoma. An immunohistochemical and immunoradiometric study.Eur J Cancer1996; 32a: 1585–90.
28.
WuM.S., ShunC.T., WangH.P., LeeW.J., WangT.H., LinJ.T.Loss of pS2 protein expression is an early event of intestinal-type gastric cancer.Jpn J Cancer Res1998; 89: 278–82.
LaurenP.The two histological main types of gastric carcinoma: diffuse and so-called intestinal type carcinomas: an attempt at a histological classification.Acta Pathol Microbiol Scand1965; 64: 31–49.
31.
BradfordM.A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding.Anal Biochem1976; 72: 248–54.
32.
MantelN., MyersM.Problems of convergence of maximum likehood iterative procedures in multiparameter situations.J Am Statist Assoc1971; 66: 484–91.
33.
CoxD.R.Regression models and life tables.J R Statist Soc B1972; 34: 187–220.
34.
MachadoJ.C., CarneiroF., BlinN., Sobrinho-SimoesM.Pattern of pS2 protein expression in premalignant and malignant lesions of gastric mucosa.Eur J Cancer Prev1996; 5: 169–79.
